UBS Group AG

Holdings History for ClearPoint Neuro, Inc. - Common Stock, $0.01 par value per share (CLPT)

Symbol: CLPT on Nasdaq
Investment type: Equity / Common Stock, $0.01 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$4,648,601	339,810	-20,895	-5.8%	$13.68	Q4 2025
30 Sep 2025	0%	+0%	$7,859,762	360,705	+205,295	+132%	$21.79	Q3 2025
30 Jun 2025	0%	+0%	$1,855,596	155,410	+60,133	+63%	$11.94	Q2 2025
31 Mar 2025	0%	+0%	$1,132,844	95,277	+49,096	+100%	$11.89	Q1 2025
31 Dec 2024	0%	+0%	$710,265	46,181	+15,213	+49%	$15.38	Q4 2024
30 Sep 2024	0%	+0%	$347,151	30,968	+1,921	+6.6%	$11.21	Q3 2024
30 Jun 2024	0%	-0%	$156,564	29,047	-22,974	-44%	$5.39	Q2 2024
31 Mar 2024	0%	-0%	$353,743	52,021	-1,510	-2.8%	$6.80	Q1 2024
31 Dec 2023	0%	+0%	$363,475	53,531	+13,958	+35%	$6.79	Q4 2023
30 Sep 2023	0%	-0%	$198,260	39,573	-3,988	-9.2%	$5.01	Q3 2023
30 Jun 2023	0%	+0%	$315,381	43,561	+11,023	+34%	$7.24	Q2 2023
31 Mar 2023	0%	+0%	$274,621	32,538	+275	+0.85%	$8.44	Q1 2023
31 Dec 2022	0%	-0%	$273,268	32,263	-4,992	-13%	$8.47	Q4 2022
30 Sep 2022	0%	+0%	$386,000	37,255	+35,149	+1669%	$10.36	Q3 2022
30 Jun 2022	0%	-0%	$27,000	2,106	-3,446	-62%	$12.82	Q2 2022
31 Mar 2022	0%	-0%	$59,000	5,552	-17,455	-76%	$10.63	Q1 2022
31 Dec 2021	0%	+0%	$258,000	23,007	+2,621	+13%	$11.21	Q4 2021
30 Sep 2021	0%	+0%	$362,000	20,386	+1,330	+7%	$17.76	Q3 2021
30 Jun 2021	0%	+0%	$364,000	19,056	+4,650	+32%	$19.10	Q2 2021
31 Mar 2021	0%	+0%	$305,000	14,406	+1,505	+12%	$21.17	Q1 2021
31 Dec 2020	0%	+0%	$205,000	12,901	+7,498	+139%	$15.89	Q4 2020
30 Sep 2020	0%	+0%	$30,000	5,403	+5,403	NEW	$5.55	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.